Last reviewed · How we verify
NCT03716713
CeraShield™ Endotracheal Tube Feasibility Study
NA trial testing CeraShield Endotracheal Tube in Intubation, Intratracheal in 10 participants. Status unknown.
30 October 2019
Quick facts
| Lead sponsor | N8 Medical, LLC |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 10 |
| Start date | 30 November 2018 |
| Primary completion | 30 October 2019 |
| Estimated completion | 30 October 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- CeraShield Endotracheal Tube
Conditions studied
- Intubation, Intratracheal — all drugs for Intubation, Intratracheal →
Sponsor
N8 Medical, LLC
Who can join
18 and older, any sex, with Intubation, Intratracheal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single-arm, feasibility study to evaluate the Ceragenin Coated Endotracheal Tube (the CeraShield ETT) in adults who require intubation and are expected to be mechanically ventilated for ≥ 24 hours.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Antimicrobial Peptide Mimics for Clinical Use: Does Size Matter?
Svenson J, Molchanova N, Schroeder CI. · · 2022 · cited 25× · PMID 35720375 · DOI 10.3389/fimmu.2022.915368 -
Ceragenin-coated endotracheal tubes for the reduction of ventilator-associated pneumonia: a prospective, longitudinal, cross-over, interrupted time, implementation study protocol (CEASE VAP study).
Symonds NE, Meng EXM, Boyd JG, Boyd T, et al · · 2024 · cited 3× · PMID 38309761 · DOI 10.1136/bmjopen-2023-076720 -
Ceragenin-Coated Endotracheal Tubes for the Reduction of Ventilator-Associated Pneumonia: A Prospective, Longitudinal, Crossover, Interrupted Time, Implementation Study (CEASE VAP Study).
Muscedere J, Norman PA, D'Arsigney C, Day AG, et al · · 2026 · PMID 41860990 · DOI 10.1097/cce.0000000000001382
Verify or expand the search:
- PubMed search for NCT03716713
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CeraShield Endotracheal Tube
Trials testing the same drug.
- NCT05761613 — Ceragenin Coated Endotracheal Tubes for the Prevention of Ventilator Associated Pneumonia · NA · active not recruiting
Other recruiting trials for Intubation, Intratracheal
Currently open trials in the same condition.
- NCT07351227 — Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment · NA · recruiting
- NCT06953414 — Classification and Prediction of Difficult Awake Tracheal Intubation With Flexible Bronchoscopes · recruiting
- NCT07185074 — Intubation Conditions During ERCP With Lidocaine Aerosol Plus Low-dose Cisatracurium or Conventional-dose Cisatracurium · Phase 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03716713 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by N8 Medical, LLC
- Last refreshed: 20 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03716713.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing